In codominant and recessive models, IL-6 –174G>C polymorphism was associated with HCC susceptibility with almost no heterogeneity, which was consistent with previous report.[16] In dominant and allele models, IL-6 –174G>C polymorphism had no influence on the risk of HCC. The gene discussed is IL6; the disease is hepatocellular carcinoma.